Sana Biotechnology, Inc. (SANA)
3.16
+0.05
(+1.61%)
USD |
NASDAQ |
May 21, 16:00
3.16
0.00 (0.00%)
After-Hours: 19:59
Sana Biotechnology Shareholders Equity (Quarterly) : 119.24M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ImmunityBio, Inc. | -870.01M |
| Vertex Pharmaceuticals, Inc. | 19.36B |
| Sarepta Therapeutics, Inc. | 1.505B |
| Beam Therapeutics, Inc. | 1.164B |
| Prelude Therapeutics, Inc. | 60.18M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 373.59M |
| Total Liabilities (Quarterly) | 254.35M |
| Debt to Equity Ratio | 0.6317 |
| Current Ratio | 1.295 |
| Net Debt Paydown Yield | 0.49% |